Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health ...

Continuous glucose monitoring (CGM) devices may overestimate blood glucose levels in healthy adults, potentially leading to unnecessary dietary changes and confusion among users, according to a recent ...

Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by ...

This blog post concludes a five-part series I ran this week on some of the keys intersecting AI and compliance. Yesterday, I wrote that businesses must proactively address the potential for bias at ...

High blood pressure has become one of the most pressing health challenges worldwide, affecting well over a billion people. Yet only about one in five individuals manages the condition effectively, a ...

Current solutions for remote health monitoring can be seen as invasive by patients and mostly do single variant intermittent tracking. FDA clearance brings one of Europe’s most advanced real-time ...

Tia Harmon (left) is a Technical Product Sales Specialist in the cell and gene therapy (CGT) space at PHC Corporation of North America (PHCNA; IL, USA) with a background in cancer research. In this ...